Modulation of contractions to ergonovine and methylergonovine by nitric oxide and thromboxane A2 in the human coronary artery

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 5, 2000, Pages 631-639

  Auch Schwelk, Wolfgang ^a,c   Paetsch, Ingo ^a   Krackhardt, Florian ^a   Gräfe, Michael ^a   Hetzer, Roland ^b   Fleck, Eckart ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

5 HT receptors; Endothelium; Ergonovine; Nitric oxide; Thromboxane; Vasospasm

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ERGOMETRINE; METHYLERGOMETRINE; N(G) NITROARGININE; NITRIC OXIDE; POTASSIUM CHLORIDE; SEROTONIN; SEROTONIN RECEPTOR; SUBSTANCE P; THROMBOXANE A2;

ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; NEUROTRANSMISSION; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASOSPASM;

EID: 0033765535     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200011000-00013     Document Type: Article

References (42)

1. Similarities of ergonovine-induced and spontaneous attacks of variant angina
2. Coronary vasospasm in angina pectoris
3. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography
4. Methergin® testing with anglographically normal coronary arteries
5. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin
6. Endothelium-derived relaxing factor and coronary vasospasm
7. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina
8. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina
9. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina
10. The interactions of platelet-derived mediators on isolated canine coronary arteries
11. 2 levels in patients with classic and variant angina pectoris
12. Specific platelet mediators and unstable coronary artery lesions
13. 2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries
14. 2-receptor agonist, U46619
15. I-N(G)-nitro arginine (I-NOARG): A novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro
16. Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries
17. Effects of ergonovine in patients with and without coronary artery disease
18. Reactivity of eccentric and concentric coronary stenoses in patients with chronic stable angina
19. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries
20. Response of human coronary arteries to aggregating platelets: Importance of endothelium-derived relaxing factor and prostanoids
21. Comparison of responses to acetylcholine and serotonin on isolated canine and human coronary arteries
22. 2 receptor activation
23. 1-like receptors resemble cloned 5-HT(1Db) receptors
24. 2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenosis
25. 2 receptors mediating vascular smooth muscle contraction
26. 5-HT receptors: Subtypes and second messengers
27. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology
28. Alignment of receptor nomenclature with the human genome: Classification of 5-HT(1B) and HT(1D) receptor subtypes
29. 1-like receptor in dog saphenous vein
30. Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomosis; involvement of 5-HT(1B/1D) and novel receptors
31. 5-HT receptors mediating contractions of the isolated human coronary artery
32. 5-Hydroxytryptamine receptor profile in healthy and diseased human coronary arteries
33. 125I]tyrosinamide labels the 5-HT(1Dα) receptor subtype in the human cortex
34. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT(1Dα) and 5-HT(1Dβ)
35. How efficacious are 5-HT(1B/D) receptor ligands: An answer from GTP gamma S binding studies with stably transfected C6-glial cell lines
36. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques
37. 5-HT(1D) receptors: A serotonin population for the 1990s
38. Agonist activity of sumatriptan and metergoline at the 5-HT(1Dβ) receptor: Further evidence for a role of the 5-HT(1D) receptor in the action of sumatriptan
39. 5-(Nonyloxy)tryptamine: A novel high-affinity 5-HT(1Db) serotonin receptor agonist
40. Paradoxical vasoconstriction inducted by acetylcholine in atherosclerotic coronary arteries
41. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis
42. Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P